معالجة الثآليل بالليفاميزول

Authors

  • محمد معلا

Abstract

أجريت هذه الدراسة على 120 مريضا بثآليل متعددة تتراوح أعمارهم بين 1- 51 سنة تم تقسيم المرضى إلى مجموعتين تتألف كل منهما من 60 مريضا. أعطيت المجموعة الأولى ليفاميزول بجرعات حسب عمر المريض (1-4 سنوات : 40 مغ ، 5-15 سنة : 80 مغ ، 16 سنة فما فوق : 120 مغ) مرة كل 15 يوم لمدة شهرين. أعطيت المجموعة الثانية علاجا مموها عبارة عن ماء مقطر الجرعات والمواعيد نفسها التي تم فيها إعطاء الليفاميزول. بعد متابعة المرضى لمدة شهرين بعد انتهاء العلاج لاحظنا نسبة شفاء الثآليل 71.67 % بالمعالجة بالليفاميزول مقارنة مع 36.67 % بالمعالجة بالعلاج المموه وهذا ما يفتح المجال أمام الليفاميزول للدخول في مجال معالجة الثآليل.

This study was made on 120 patients with multiple warts. The patients’ age ranged between 1 – 51 years. The patients had been devided into 2 groups. The first group was treated with levamizole in doses according to the patients’ age (1 – 4 years : 40mg, 5 – 15 years : 80 mg, 16 years and more : 120 mg) once every 15 days  for 2 months. The  second group received  placebo in the same way.

two months after the end of treatment the cure rate was 71.67 with levamizole treated group, while it was only 36.67 with placebo. These results may allow levamizole to enter in the treatment of warts .

Downloads

Published

2019-02-11

How to Cite

1.
معلا م. معالجة الثآليل بالليفاميزول. Tuj-hlth [Internet]. 2019Feb.11 [cited 2024May7];25(2). Available from: https://journal.tishreen.edu.sy/index.php/hlthscnc/article/view/8111

Issue

Vol. 25 No. 2 (2003): العلوم الصحية

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

The authors retain the copyright and grant the right to publish in the magazine for the first time with the transfer of the commercial right to Tishreen University Journal for Research and Scientific Studies - Health Sciences Series

 Under a CC BY- NC-SA 04 license that allows others to share the work with of the work's authorship and initial publication in this journal. Authors can use a copy of their articles in their scientific activity, and on their scientific websites, provided that the place of publication is indicted in  Tishreen University Journal for Research and Scientific Studies - Health Sciences Series   .  The Readers have the right to send, print and subscribe to the initial version of the article, and the title of  Tishreen University Journal for Research and Scientific Studies - Health Sciences Series  Publisher

journal uses a CC BY-NC-SA license which mean

You are free to:

  • Adapt — remix, transform, and build upon the material
  •  
  • The licensor cannot revoke these freedoms as long as you follow the license terms.

 

  • Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
  • NonCommercial — You may not use the material for commercial purposes.
  • ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
  • No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.

Most read articles by the same author(s)